Dual targeting of G9a and DNMT1 for the treatment of experimental cholangiocarcinoma
2021-01-01 Colyn, Leticia; Bárcena-Varela, Marina; Álvarez-Sola, Gloria; Latasa, M Ujue; Uriarte, Iker; Santamaría, Eva; Herranz, Jose M; Santos-Laso, Alvaro; Arechederra, Maria; Ruiz De Gauna, Mikel; Aspichueta, Patricia; Canale, Matteo; Casadei-Gardini, Andrea; Francesconi, Maria; Carotti, Simone; Morini, Sergio; Nelson, Leonard J; Iraburu, Maria J; Chen, Chaobo; Sangro, Bruno; Marin, Jose Jg; Martinez-Chantar, Maria L; Banales, Jesus M; Arnes, Robert; Huch, Meritxell; Patino, John; Dar, Altaf A; Nosrati, Mehdi; Oyarzábal, Julen; Prósper, Felipe; Urman, Jesus; Cubero, Francisco Javier; Trautwein, Christian; Berasain, Carmen; Fernandez-Barrena, Maite G; Avila, Matias A
BRCA in gastrointestinal cancers: Current treatments and future perspectives
2020-01-01 Molinaro, E.; Andrikou, K.; Casadei Gardini, A.; Rovesti, G.
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib
2021-01-01 Casadei Gardini, A.; Rovesti, G.; Dadduzio, V.; Vivaldi, C.; Lai, E.; Lonardi, S.; Fornaro, L.; Pretta, A.; Zagonel, V.; Bernardini, L.; Astara, G.; D'Amico, F. E.; Masi, G.; Rimini, M.; Scartozzi, M.; Cascinu, S.
Child Pugh and ALBI grade: past, present or future?
2020-01-01 Rimini, Margherita; Rovesti, Giulia; Casadei-Gardini, Andrea
ROS1 rearrangements are uncommon in biliary tract cancers
2020-01-01 Mazzoni, F.; Petreni, P.; Vasile, E.; Panebianco, M.; Casadei Gardini, A.; Negri, F.; Lunghi, A.; Pillozzi, S.; Vivaldi, C.; Gervasi, E.; Frassineti, G. L.; Messerini, L.; Jocolle, G.; Bisagni, A.; Antonuzzo, L.; Rossi, G.
Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial
2020-01-01 Casadei Gardini, A.; Scarpi, E.; Valgiusti, M.; Monti, M.; Ruscelli, S.; Matteucci, L.; Bartolini, G.; Vertogen, B.; Pagan, F.; Rovesti, G.; Frassineti, G. L.; Passardi, A.
Epigenetic mechanisms in gastric cancer: Potential new therapeutic opportunities
2020-01-01 Canale, M.; Casadei Gardini, A.; Ulivi, P.; Arechederra, M.; Berasain, C.; Lollini, P. -L.; Fernandez-Barrena, M. G.; Avila, M. A.
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
2020-01-01 Vivaldi, C.; Salani, F.; Rovesti, G.; Pecora, I.; Catanese, S.; Casadei Gardini, A.; Massa, V.; Bernardini, L.; Riggi, L.; Andrikou, K.; Rapposelli, G. I.; Formica, V.; Lencioni, M.; Falcone, A.; Vasile, E.; Fornaro, L.
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment
2020-01-01 Roviello, G.; Casadei Gardini, A.; Nobili, S.; Mini, E.; Fancelli, S.
Comment on Chun et al, “A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases”
2020-01-01 Gelsomino, F.; Spallanzani, A.; Casadei Gardini, A.
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer
2020-01-01 Neuzillet, C.; Casadei Gardini, A.; Brieau, B.; Vivaldi, C.; Brandi, G.; Tougeron, D.; Filippi, R.; Vienot, A.; Silvestris, N.; Pointet, A. -L.; Lonardi, S.; Rousseau, B.; Scartozzi, M.; Dahan, L.; Aprile, G.; Le Sourd, S.; Evesque, L.; Meurisse, A.; Lievre, A.; Vernerey, D.
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib
2020-01-01 Casadei Gardini, A.; Dadduzio, V.; Rovesti, G.; Cabibbo, G.; Vukotic, R.; Rizzato, M. D.; Orsi, G.; Rossi, M.; Guarneri, V.; Lonardi, S.; D'Agostino, D.; Celsa, C.; Andreone, P.; Zagonel, V.; Scartozzi, M.; Cascinu, S.; Cucchetti, A.
Mtor pathway expression as potential predictive biomarker in patients with advanced neuroendocrine tumors treated with everolimus
2020-01-01 Gelsomino, F.; Casadei-Gardini, A.; Caputo, F.; Rossi, G.; Bertolini, F.; Petrachi, T.; Spallanzani, A.; Pettorelli, E.; Kaleci, S.; Luppi, G.
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
2020-01-01 Caputo, F.; Dadduzio, V.; Tovoli, F.; Bertolini, G.; Cabibbo, G.; Cerma, K.; Vivaldi, C.; Faloppi, L.; Rizzato, M. D.; Piscaglia, F.; Celsa, C.; Fornaro, L.; Marisi, G.; Conti, F.; Silvestris, N.; Silletta, M.; Lonardi, S.; Granito, A.; Stornello, C.; Massa, V.; Astara, G.; Delcuratolo, S.; Cascinu, S.; Scartozzi, M.; Casadei Gardini, A.
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2020-01-01 Casadei Gardini, A; Marisi, G; Dadduzio, V; Gramantieri, L; Faloppi, L; Ulivi, P; Foschi, Fg; Tamburini, E; Vivaldi, C; Rizzato, Md; Ielasi, L; Canale, M; Conti, F; Rudnas, B; Fornaro, L; Silvestris, N; Silletta, M; Cardellino, Gg; Lonardi, S; Fornari, F; Orsi, G; Rovesti, G; Zagonel, V; Cascinu, S; Scartozzi, M
The role of anti-angiogenics in pre-treated metastatic BRAF-mutant colorectal cancer: A pooled analysis
2020-01-01 Gelsomino, F.; Casadei Gardini, A.; Rossini, D.; Boccaccino, A.; Masi, G.; Cremolini, C.; Spallanzani, A.; Giuseppe Viola, M.; Garajov�, I.; Salati, M.; Teresa Elia, M.; Caputo, F.; Santini, C.; Falcone, A.; Cascinu, S.; Tamburini, E.
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study
2020-01-01 Rimini, Margherita; Casadei-Gardini, Andrea; Ravaioli, Alessandra; Rovesti, Giulia; Conti, Fabio; Borghi, Alberto; Dall'Aglio, Anna Chiara; Bedogni, Giorgio; Domenicali, Marco; Giacomoni, Pierluigi; Tiribelli, Claudio; Bucchi, Lauro; Falcini, Fabio; Foschi, Francesco Giuseppe; Bagnacavallo Study Group, Null
Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-Analysis
2020-01-01 Casadei Gardini, A.; Vagheggini, A.; Gelsomino, F.; Spallanzani, A.; Ulivi, P.; Orsi, G.; Rovesti, G.; Andrikou, K.; Tamburini, E.; Scartozzi, M.; Cascinu, S.
The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT
2020-01-01 de la Torre-Alaez, M.; Jordan-Iborra, C.; Casadei Gardini, A.; Bilbao, J. I.; Rodriguez-Fraile, M.; Sancho, L.; D'Avola, D.; Herrero, J. I.; Inarrairaegui, M.; Sangro, B.
The perceived ability of gastroenterologists, hepatologists and surgeons can bias medical decision making
2020-01-01 Cucchetti, A.; Evans, D.; Casadei Gardini, A.; Piscaglia, F.; Maroni, L.; Odaldi, F.; Ercolani, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Dual targeting of G9a and DNMT1 for the treatment of experimental cholangiocarcinoma | 1-gen-2021 | Colyn, Leticia; Bárcena-Varela, Marina; Álvarez-Sola, Gloria; Latasa, M Ujue; Uriarte, Iker; Santamaría, Eva; Herranz, Jose M; Santos-Laso, Alvaro; Arechederra, Maria; Ruiz De Gauna, Mikel; Aspichueta, Patricia; Canale, Matteo; Casadei-Gardini, Andrea; Francesconi, Maria; Carotti, Simone; Morini, Sergio; Nelson, Leonard J; Iraburu, Maria J; Chen, Chaobo; Sangro, Bruno; Marin, Jose Jg; Martinez-Chantar, Maria L; Banales, Jesus M; Arnes, Robert; Huch, Meritxell; Patino, John; Dar, Altaf A; Nosrati, Mehdi; Oyarzábal, Julen; Prósper, Felipe; Urman, Jesus; Cubero, Francisco Javier; Trautwein, Christian; Berasain, Carmen; Fernandez-Barrena, Maite G; Avila, Matias A | |
| BRCA in gastrointestinal cancers: Current treatments and future perspectives | 1-gen-2020 | Molinaro, E.; Andrikou, K.; Casadei Gardini, A.; Rovesti, G. | |
| Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib | 1-gen-2021 | Casadei Gardini, A.; Rovesti, G.; Dadduzio, V.; Vivaldi, C.; Lai, E.; Lonardi, S.; Fornaro, L.; Pretta, A.; Zagonel, V.; Bernardini, L.; Astara, G.; D'Amico, F. E.; Masi, G.; Rimini, M.; Scartozzi, M.; Cascinu, S. | |
| Child Pugh and ALBI grade: past, present or future? | 1-gen-2020 | Rimini, Margherita; Rovesti, Giulia; Casadei-Gardini, Andrea | |
| ROS1 rearrangements are uncommon in biliary tract cancers | 1-gen-2020 | Mazzoni, F.; Petreni, P.; Vasile, E.; Panebianco, M.; Casadei Gardini, A.; Negri, F.; Lunghi, A.; Pillozzi, S.; Vivaldi, C.; Gervasi, E.; Frassineti, G. L.; Messerini, L.; Jocolle, G.; Bisagni, A.; Antonuzzo, L.; Rossi, G. | |
| Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial | 1-gen-2020 | Casadei Gardini, A.; Scarpi, E.; Valgiusti, M.; Monti, M.; Ruscelli, S.; Matteucci, L.; Bartolini, G.; Vertogen, B.; Pagan, F.; Rovesti, G.; Frassineti, G. L.; Passardi, A. | |
| Epigenetic mechanisms in gastric cancer: Potential new therapeutic opportunities | 1-gen-2020 | Canale, M.; Casadei Gardini, A.; Ulivi, P.; Arechederra, M.; Berasain, C.; Lollini, P. -L.; Fernandez-Barrena, M. G.; Avila, M. A. | |
| First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age? | 1-gen-2020 | Vivaldi, C.; Salani, F.; Rovesti, G.; Pecora, I.; Catanese, S.; Casadei Gardini, A.; Massa, V.; Bernardini, L.; Riggi, L.; Andrikou, K.; Rapposelli, G. I.; Formica, V.; Lencioni, M.; Falcone, A.; Vasile, E.; Fornaro, L. | |
| Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment | 1-gen-2020 | Roviello, G.; Casadei Gardini, A.; Nobili, S.; Mini, E.; Fancelli, S. | |
| Comment on Chun et al, “A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases” | 1-gen-2020 | Gelsomino, F.; Spallanzani, A.; Casadei Gardini, A. | |
| Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer | 1-gen-2020 | Neuzillet, C.; Casadei Gardini, A.; Brieau, B.; Vivaldi, C.; Brandi, G.; Tougeron, D.; Filippi, R.; Vienot, A.; Silvestris, N.; Pointet, A. -L.; Lonardi, S.; Rousseau, B.; Scartozzi, M.; Dahan, L.; Aprile, G.; Le Sourd, S.; Evesque, L.; Meurisse, A.; Lievre, A.; Vernerey, D. | |
| Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib | 1-gen-2020 | Casadei Gardini, A.; Dadduzio, V.; Rovesti, G.; Cabibbo, G.; Vukotic, R.; Rizzato, M. D.; Orsi, G.; Rossi, M.; Guarneri, V.; Lonardi, S.; D'Agostino, D.; Celsa, C.; Andreone, P.; Zagonel, V.; Scartozzi, M.; Cascinu, S.; Cucchetti, A. | |
| Mtor pathway expression as potential predictive biomarker in patients with advanced neuroendocrine tumors treated with everolimus | 1-gen-2020 | Gelsomino, F.; Casadei-Gardini, A.; Caputo, F.; Rossi, G.; Bertolini, F.; Petrachi, T.; Spallanzani, A.; Pettorelli, E.; Kaleci, S.; Luppi, G. | |
| The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib | 1-gen-2020 | Caputo, F.; Dadduzio, V.; Tovoli, F.; Bertolini, G.; Cabibbo, G.; Cerma, K.; Vivaldi, C.; Faloppi, L.; Rizzato, M. D.; Piscaglia, F.; Celsa, C.; Fornaro, L.; Marisi, G.; Conti, F.; Silvestris, N.; Silletta, M.; Lonardi, S.; Granito, A.; Stornello, C.; Massa, V.; Astara, G.; Delcuratolo, S.; Cascinu, S.; Scartozzi, M.; Casadei Gardini, A. | |
| Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study | 1-gen-2020 | Casadei Gardini, A; Marisi, G; Dadduzio, V; Gramantieri, L; Faloppi, L; Ulivi, P; Foschi, Fg; Tamburini, E; Vivaldi, C; Rizzato, Md; Ielasi, L; Canale, M; Conti, F; Rudnas, B; Fornaro, L; Silvestris, N; Silletta, M; Cardellino, Gg; Lonardi, S; Fornari, F; Orsi, G; Rovesti, G; Zagonel, V; Cascinu, S; Scartozzi, M | |
| The role of anti-angiogenics in pre-treated metastatic BRAF-mutant colorectal cancer: A pooled analysis | 1-gen-2020 | Gelsomino, F.; Casadei Gardini, A.; Rossini, D.; Boccaccino, A.; Masi, G.; Cremolini, C.; Spallanzani, A.; Giuseppe Viola, M.; Garajov�, I.; Salati, M.; Teresa Elia, M.; Caputo, F.; Santini, C.; Falcone, A.; Cascinu, S.; Tamburini, E. | |
| Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study | 1-gen-2020 | Rimini, Margherita; Casadei-Gardini, Andrea; Ravaioli, Alessandra; Rovesti, Giulia; Conti, Fabio; Borghi, Alberto; Dall'Aglio, Anna Chiara; Bedogni, Giorgio; Domenicali, Marco; Giacomoni, Pierluigi; Tiribelli, Claudio; Bucchi, Lauro; Falcini, Fabio; Foschi, Francesco Giuseppe; Bagnacavallo Study Group, Null | |
| Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-Analysis | 1-gen-2020 | Casadei Gardini, A.; Vagheggini, A.; Gelsomino, F.; Spallanzani, A.; Ulivi, P.; Orsi, G.; Rovesti, G.; Andrikou, K.; Tamburini, E.; Scartozzi, M.; Cascinu, S. | |
| The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT | 1-gen-2020 | de la Torre-Alaez, M.; Jordan-Iborra, C.; Casadei Gardini, A.; Bilbao, J. I.; Rodriguez-Fraile, M.; Sancho, L.; D'Avola, D.; Herrero, J. I.; Inarrairaegui, M.; Sangro, B. | |
| The perceived ability of gastroenterologists, hepatologists and surgeons can bias medical decision making | 1-gen-2020 | Cucchetti, A.; Evans, D.; Casadei Gardini, A.; Piscaglia, F.; Maroni, L.; Odaldi, F.; Ercolani, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39411
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711498
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.771
- John Wiley and Sons Inc525
- Springer Science and Business Med...522
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer362
- MDPI347
- Elsevier Ltd330
- Springer Nature282
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28818
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33631
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1